CRP and hereditary hemorrhagic telangiectasia: Accordingly, we used the flow cytometric platelet aggregation analysis and found no difference in platelet aggregation response in HHT-patients compared with the control group for any used agonist (ADP, TRAP and CRP), see Fig. 2.